Effect of Water-miscible Organic Solvents on CYP450-mediated Metoprolol and Imipramine Metabolism in Rat Liver Microsomes

Overview

Journal Indian J Pharm Sci

Specialty Pharmacy

Date 2015 Dec 15

PMID 26664053

Citations 4

Authors

T S Shah

S H Kamble

Pranali G Patil

K R Iyer

Affiliations

Soon will be listed here.

Abstract

The catalytic activity of cytochrome P450 enzymes is known to be affected by presence of organic solvents in in vitro assays. However, these effects tend to be variable and depend on the substrate and CYP450 isoform in question. In the present study, we have investigated effect of ten water miscible organic solvents (methanol, ethanol, propanol, isopropanol, acetone, acetonitrile, dimethylsulphoxide, dimethylformamide, dioxane and PEG400) on water soluble substrates of CYP450, metoprolol and imipramine, at 0, 0.1, 0.25, 0.5, 0.75 and 1% v/v concentration in rat liver microsomes. Organic solvents studied had a concentration dependent inhibitory effect on the metoprolol and imipramine metabolism activity. Metoprolol metabolism was found to be more susceptible to the organic solvents, almost all the ten solvents had more or less inhibitory effect compared to imipramine metabolism. Except acetone, PEG400 and dimethylsulphoxide, all solvents had ~50% inhibition of total metoprolol metabolism activity, while in case of imipramine metabolism activity, only n-propanol, isopropanol and PEG400 had ~50% inhibition at 1% v/v. Interestingly, methanol, dimethylsulphoxide and acetonitrile had negligible effect on the imipramine metabolism (less than 10% inhibition at 1% v/v) while, total metoprolol metabolism activity was substantially inhibited by these solvents (MeOH 52%, DMSO 29% and ACN 47% at 1% v/v). In both cases, dioxane was found to be the most inhibitory solvent (~90% inhibition at 1% v/v).

Citing Articles

Detrimental Impacts of Pharmaceutical Excipient PEG400 on Gut Microbiota and Metabolome in Healthy Mice.

Zhao M, Wang P, Sun X, Yang D, Zhang S, Meng X Molecules. 2023; 28(22).

PMID: 38005284 PMC: 10673170. DOI: 10.3390/molecules28227562.

Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in Rats.

Kamble S, Obeng S, Leon F, Restrepo L, King T, Berthold E J Pharmacol Exp Ther. 2023; 385(3):180-192.

PMID: 37019472 PMC: 10201580. DOI: 10.1124/jpet.122.001525.

Metabolism of Speciociliatine, an Overlooked Kratom Alkaloid for its Potential Pharmacological Effects.

Kamble S, Berthold E, Kanumuri S, King T, Kuntz M, Leon F AAPS J. 2022; 24(5):86.

PMID: 35854066 PMC: 9932950. DOI: 10.1208/s12248-022-00736-8.

Metabolism of a Kratom Alkaloid Metabolite in Human Plasma Increases Its Opioid Potency and Efficacy.

Kamble S, Leon F, King T, Berthold E, Lopera-Londono C, Raju K ACS Pharmacol Transl Sci. 2020; 3(6):1063-1068.

PMID: 33344889 PMC: 7737207. DOI: 10.1021/acsptsci.0c00075.

References

Riley R, McGinnity D, Austin R . A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes. Drug Metab Dispos. 2005; 33(9):1304-11. DOI: 10.1124/dmd.105.004259. View

Gonzalez-Perez V, Connolly E, Bridges A, Wienkers L, Paine M . Impact of organic solvents on cytochrome P450 probe reactions: filling the gap with (S)-Warfarin and midazolam hydroxylation. Drug Metab Dispos. 2012; 40(11):2136-42. PMC: 3477202. DOI: 10.1124/dmd.112.047134. View

Tang C, Shou M, Rodrigues A . Substrate-dependent effect of acetonitrile on human liver microsomal cytochrome P450 2C9 (CYP2C9) activity. Drug Metab Dispos. 2000; 28(5):567-72. View

Bull S, Catalani P, Garle M, Coecke S, Clothier R . Imipramine for Cytochrome P450 Activity Determination: a Multiple-species Metabolic Probe. Toxicol In Vitro. 2010; 13(4-5):537-41. DOI: 10.1016/s0887-2333(99)00022-3. View

Hickman D, Wang J, Wang Y, Unadkat J . Evaluation of the selectivity of In vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activities. Drug Metab Dispos. 1998; 26(3):207-15. View

Backes W, CANADY W . The interaction of hepatic cytochrome P-450 with organic solvents. The effect of organic solvents on apparent spectral binding constants for hydrocarbon substrates. J Biol Chem. 1981; 256(14):7213-27. View

Kumar S, Earla R, Jin M, Mitra A, Kumar A . Effect of ethanol on spectral binding, inhibition, and activity of CYP3A4 with an antiretroviral drug nelfinavir. Biochem Biophys Res Commun. 2010; 402(1):163-7. DOI: 10.1016/j.bbrc.2010.10.014. View

Obach R . Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metab Dispos. 1999; 27(11):1350-9. View

Busby Jr W, Ackermann J, Crespi C . Effect of methanol, ethanol, dimethyl sulfoxide, and acetonitrile on in vitro activities of cDNA-expressed human cytochromes P-450. Drug Metab Dispos. 1999; 27(2):246-9. View

10.

Lennard M . Quantitative analysis of metoprolol and three of its metabolites in urine and liver microsomes by high-performance liquid chromatography. J Chromatogr. 1985; 342(1):199-205. DOI: 10.1016/s0378-4347(00)84504-1. View

11.

Rokitta D, Pfeiffer K, Streich C, Gerwin H, Fuhr U . The effect of organic solvents on enzyme kinetic parameters of human CYP3A4 and CYP1A2 in vitro. Toxicol Mech Methods. 2013; 23(8):576-83. DOI: 10.3109/15376516.2013.806622. View

12.

Lewis D, Jacobs M, Dickins M . Compound lipophilicity for substrate binding to human P450s in drug metabolism. Drug Discov Today. 2004; 9(12):530-7. DOI: 10.1016/S1359-6446(04)03115-0. View

13.

Lin J, Lu A . Inhibition and induction of cytochrome P450 and the clinical implications. Clin Pharmacokinet. 1998; 35(5):361-90. DOI: 10.2165/00003088-199835050-00003. View

14.

Lemoine A, GAUTIER J, Azoulay D, Kiffel L, Belloc C, Guengerich F . Major pathway of imipramine metabolism is catalyzed by cytochromes P-450 1A2 and P-450 3A4 in human liver. Mol Pharmacol. 1993; 43(5):827-32. View

15.

Chiba M, Fujita S, Suzuki T . Kinetic properties of the metabolism of imipramine and desipramine in isolated rat hepatocytes. Biochem Pharmacol. 1990; 39(2):367-72. DOI: 10.1016/0006-2952(90)90036-k. View

16.

Lennard M, Crewe H, Tucker G, Woods H . Metoprolol oxidation by rat liver microsomes. Inhibition by debrisoquine and other drugs. Biochem Pharmacol. 1986; 35(16):2757-61. DOI: 10.1016/0006-2952(86)90186-3. View

17.

Easterbrook J, Lu C, Sakai Y, Li A . Effects of organic solvents on the activities of cytochrome P450 isoforms, UDP-dependent glucuronyl transferase, and phenol sulfotransferase in human hepatocytes. Drug Metab Dispos. 2001; 29(2):141-4. View

18.

Wienkers L, Heath T . Predicting in vivo drug interactions from in vitro drug discovery data. Nat Rev Drug Discov. 2005; 4(10):825-33. DOI: 10.1038/nrd1851. View

19.

Chauret N, Gauthier A . Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes. Drug Metab Dispos. 1998; 26(1):1-4. View

20.

Aasa J, Hu Y, Eklund G, Lindgren A, Baranczewski P, Malmquist J . Effect of solvents on the time-dependent inhibition of CYP3A4 and the biotransformation of AZD3839 in human liver microsomes and hepatocytes. Drug Metab Dispos. 2012; 41(1):159-69. DOI: 10.1124/dmd.112.047597. View